DART ROBINHOOD THINGS TO KNOW BEFORE YOU BUY

Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where remedy solutions remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy